Edwards Lifesciences Earnings beat, Revenue misses In Q3
Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.06 on revenue of $921M. Analysts polled by Investing.com expected EPS of $1.02 on revenue of $928.5M. That compared to EPS of $0.84 on revenue of $821.5M in the same period a year earlier. The company had reported EPS of $1.24 on revenue of $972.1M in the previous quarter.
Edwards Lifesciences shares slightly moved 0.00% to trade at $148.30 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are up 32.79%, outperforming the S&P 500 which is up 2.12% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on Thursday, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
DoJ probing AmEx's foreign exchange international payments unit
Day Ahead: Top 3 Things to Watch
Target expands delivery, pickup options ahead of U.S. holiday season
